DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease

Summary

This is a prospective, randomized, double-blind, double-dummy, and controlled study of DLBS1033 for the improvement of ankle-brachial index in diabetic patients with peripheral arterial disease (PAD). It is hypothesized that the addition of DLBS1033 on top of aspirin treatment will augment significantly the resting ABI in diabetes patient with PAD in comparison with that of aspirin alone.

Timeline

Start

2015-06-03

Primary completion

2018-06

Completion

2018-07

Drugs

Indications